The text discusses recommendations for adjuvant chemotherapy for colorectal cancer, including the use of 5-FU oral and oxaliplatin in certain cases, genotyping of the DPYD gene, encouraging moderate physical activity, and considering the use of raltitrexed and oxaliplatin in specific situations. It also mentions a clinical trial evaluating adjuvant chemotherapy in older patients with stage III colon cancer.